| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/16/2006 | WO2004091491A3 Profiling conformational variants, antibody compositions and methods of using the same |
| 02/16/2006 | WO2004083448A3 Molecular differences between species of the m.tuberculosis complex |
| 02/16/2006 | WO2004047720A3 Methods of inhibiting angiogensis via modification of a lysyl oxidase |
| 02/16/2006 | WO2004014292A3 EphA2 AGONISTIC MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF |
| 02/16/2006 | WO2003083058A3 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 02/16/2006 | WO2003025129A3 Neurotransmission-associated proteins |
| 02/16/2006 | US20060037107 Production of antibodies |
| 02/16/2006 | US20060037093 Transgenic transchromosomal rodents for making human antibodies |
| 02/16/2006 | US20060036420 Three-dimensional model of a complex between a Fc epsilon receptor alpha chain and a Fc region of an IgE antibody and uses thereof |
| 02/16/2006 | US20060036089 33 human secreted proteins |
| 02/16/2006 | US20060036082 Method of obtaining cell lines in a protein-free medium and cell lines thus obtained |
| 02/16/2006 | US20060036076 Metalloproteinase-binding proteins |
| 02/16/2006 | US20060036074 Bromodomain protein |
| 02/16/2006 | US20060036070 Immunoglobulin a inducing protein and uses therefor |
| 02/16/2006 | US20060035907 Methods of treating abnormal cell growth using c-MET and m-TOR inhibitors |
| 02/16/2006 | US20060035856 Purified polypeptides having IL-13 receptor activity |
| 02/16/2006 | US20060035855 Purified polypeptides having IL-13 receptor activity |
| 02/16/2006 | US20060035852 Genetic products differentially expressed in tumors and the use thereof |
| 02/16/2006 | US20060035835 Novel protein, production and use thereof |
| 02/16/2006 | US20060035825 Alpha 5 beta 1 and its ability to regulate the cell survival pathway |
| 02/16/2006 | US20060035389 Immobilization of glycorproteins |
| 02/16/2006 | US20060035337 Leukocyte adhesion inhibitor-1 polypeptide for use in the treatment of cancer, tumors, chronic infections, leukemia, T-cell mediated auto-immune diseases, parasitic infections, psoriasis, asthma, allergy, to regulate hematopoiesis, to stimulate growth factor activity, to inhibit angiogenesis |
| 02/16/2006 | US20060035331 G-protein coupled receptors |
| 02/16/2006 | US20060035330 Non aggregating fluorescent proteins and methods for using the same |
| 02/16/2006 | US20060035328 Artery-and vein-specific proteins and uses therefor |
| 02/16/2006 | US20060035326 Genes |
| 02/16/2006 | US20060035315 Transporters and ion channels |
| 02/16/2006 | US20060035297 Reagents and methods for mycophenolic acid immunoassay |
| 02/16/2006 | US20060035296 Method for detecting acetyltransferase and deacetylase activities and method for screening inhibitors or enhancers of these enzymes |
| 02/16/2006 | US20060035293 Antibodies, polypeptides and polynucleotides, used for detection, prevention and treatment of diseases caused by gramnegative bacteria |
| 02/16/2006 | US20060035284 Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroup B epitopes |
| 02/16/2006 | US20060035279 Anti-GPE antibodies, their uses and assays for weakly immunogenic molecules |
| 02/16/2006 | US20060035260 Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses |
| 02/16/2006 | US20060035232 making in vitro peptide expression libraries and for the isolation of nucleotide sequences encoding peptides of interest; constructing and screening DNA libraries for DNA sequences that encode biologically active molecules |
| 02/16/2006 | US20060035216 recombinant nucleic acid; isotopic, fluorescent, chemiluminescent, enzymatic, or hapten probe; cloning vector of the nucleic acid; host cell with improved exogenous expression of the nucleic acid; biodegradation; pollution control |
| 02/16/2006 | US20060035213 POSH nucleic acids, polypeptides and related methods |
| 02/16/2006 | US20060034864 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 02/16/2006 | US20060034861 HCV E1 comprising specific disulfide bridges |
| 02/16/2006 | US20060034858 A beta or an immunogenic fragment thereof presented by a virus or bacteria as part of an immunogenic composition effective to induce an immunogenic response comprising antibodies against A beta |
| 02/16/2006 | US20060034855 Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein |
| 02/16/2006 | US20060034852 Comprising transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) receptor moiety and an immunoglobulin moiety comprising a heavy chain constant region of an immunoglobulin; interfere with binding of a tumor necrosis factor receptor with its ligand; antitumor agents |
| 02/16/2006 | US20060034850 Antibodies as T cell receptor mimics, methods of production and uses thereof |
| 02/16/2006 | US20060034849 Antibodies reactive with beta (1-3)-glucans |
| 02/16/2006 | US20060034845 Single domain antibodies directed against tumor necrosis factor alpha and uses therefor |
| 02/16/2006 | US20060034842 Treating ErbB2-expressing breast cancer in a human by administering huMAb4D5-8 antibody and humanized 2C4 antibody variant 574 |
| 02/16/2006 | US20060034840 ErbB antagonists for pain therapy |
| 02/16/2006 | US20060034839 Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor |
| 02/16/2006 | US20060034838 Anti-human VEGF receptor Flt-1 monoclonal antibody |
| 02/16/2006 | US20060034836 administering immunoglobulins linked to proteins having amino acid replacements in the amino acid sequence, to increase the circulating half-life in vivo than a corresponding antibody-based fusion proteins without amino acid replacements; reducing tumor size and metastasis in mammals |
| 02/16/2006 | US20060034835 Immunoglobulin variants and uses thereof |
| 02/16/2006 | US20060034834 Intrabody-mediated control of immune reactions |
| 02/16/2006 | US20060034833 Single domain antibodies directed against interferron-gamma and uses therefor |
| 02/16/2006 | US20060034830 Immunoglobulins comprising predominantly a GalGlcNAcMan5GLcNAc2 glycoform |
| 02/16/2006 | US20060034829 Immunoglobulins comprising predominantly a MAN3GLCNAC2 glycoform |
| 02/16/2006 | US20060034827 Stabilized liquid anti-rsv antibody formulations |
| 02/16/2006 | US20060034826 contacting an immune cell with an agent that modulates the interaction between PD-1 and a PD-1 ligand (e.g., soluble forms of PD-1 or PD-1 ligand or antibodies to PD-1); inhibits signaling via PD-1 |
| 02/16/2006 | US20060034767 Targeting and tracking of cells to specific organs and tissues in vivo |
| 02/16/2006 | US20060034759 Production and use of novel peptide-based agents with bispecific antibodies |
| 02/16/2006 | CA2576627A1 Angiogenic and immunologic applications of anti-cd160 specific compounds obtainable from mab cl1-r2 |
| 02/16/2006 | CA2576415A1 Knockout nonhuman animal |
| 02/16/2006 | CA2576405A1 Antibody and utilization of the same |
| 02/16/2006 | CA2575791A1 Hk1-binding proteins |
| 02/16/2006 | CA2575607A1 Therapeutic and diagnostic methods and compositions targeting 4ig-b7-h3 and its counterpart nk cell receptor |
| 02/16/2006 | CA2573313A1 Antibodies against cancer produced using masked cancer cells as immunogen |
| 02/16/2006 | CA2570324A1 Rage fusion proteins and methods of use |
| 02/15/2006 | EP1626096A2 In vitro method of detecting a cell proliferative disorder involving fibroblast growth factor homologous factor-1 (FHF-1) |
| 02/15/2006 | EP1626084A1 Compositions and methods for the diagnosis of tumours |
| 02/15/2006 | EP1626059A1 Angiogenic and immunologic applications of anti-CD160 specific compounds obtainable from mAb CL1-R2 |
| 02/15/2006 | EP1626058A1 Compositions and methods for the diagnosis of tumour |
| 02/15/2006 | EP1626055A2 Non-mammalian GnRH analogs and uses thereof in the regulation of the immune system |
| 02/15/2006 | EP1625402A2 Detection, characterization and treatment of viral infection and methods thereof |
| 02/15/2006 | EP1625393A2 Method for selecting and producing vaccine components and vaccines based thereon |
| 02/15/2006 | EP1625209A2 Immunoglobulin chimeric monomer-dimer hybrids |
| 02/15/2006 | EP1625166A1 Antibodies to masp-2 |
| 02/15/2006 | EP1625165A2 Inhibitors of integrin alpha5beta1 and their use for the control of tissue granulation |
| 02/15/2006 | EP1625164A1 Method of detecting probnp with a monoclonal antibody binding to the amino acids 41-46 |
| 02/15/2006 | EP1625163A1 Method of detecting probnp with a monoclonal antibody binding to the amino acids 38-44 |
| 02/15/2006 | EP1625162A2 Compositions and methods for treatment of cryptococcosis |
| 02/15/2006 | EP1624892A2 Therapeutic use of anti-cs1 antibodies |
| 02/15/2006 | EP1624891A2 Clotting factor-fc chimeric proteins to treat hemophilia |
| 02/15/2006 | EP1624850A2 Compositions and methods for treatment of severe acute respiratory syndrome (sars) |
| 02/15/2006 | EP1624846A2 Inhibition of drug binding to serum albumin |
| 02/15/2006 | EP1481057B1 System and method for the production of recombinant glycosylated proteins in a prokaryotic host |
| 02/15/2006 | EP1379274A4 Methods for inhibition of angiogenesis, tumor growth and metastasis by fully human anti-il8 and anti-muc18 in diverse types of tumors |
| 02/15/2006 | EP1065269B1 Genomic gene encoding hm1.24 antigen protein and promoter thereof |
| 02/15/2006 | EP0762892B1 Diphtheria toxin vaccines bearing a mutated r domain |
| 02/15/2006 | CN1735689A Bacterial virulence genes |
| 02/15/2006 | CN1735630A Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
| 02/15/2006 | CN1735629A Single domain antibodies directed against tumor necrosis factor alpha and uses therefor |
| 02/15/2006 | CN1735628A Polypeptides F' of the hepatitis c virus, epitopes, and the diagnostic and therapeutic applications thereof |
| 02/15/2006 | CN1735433A Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 02/15/2006 | CN1735422A Pept¿¼deos antimicrobianos de novispirin |
| 02/15/2006 | CN1735346A Cell separation compositions methods |
| 02/15/2006 | CN1733918A Motilin homologs |
| 02/15/2006 | CN1733913A High purity venom kininogenase prepartion method and its pharmaceutical formulation |
| 02/15/2006 | CN1733910A Mononal antibody against avermectin, hybridoma cell line secreting the same and its preparation method |
| 02/15/2006 | CN1733805A Preparation technology of immune globulin against aeromonas hydrophila |
| 02/15/2006 | CN1733804A Single-chain antibody P1D3 counteracting prawn white spot syndrome virus and its preparation method |
| 02/15/2006 | CN1733800A Outer surface proteins, their genes, and their use |
| 02/15/2006 | CN1241945C Hybrid protein for inhibiting the deatanulation of mastocytes and the use thereof |